Article Text
Chronic obstructive pulmonary disease
Do inhaled corticosteroids decrease the risk of cardiovascular outcomes in patients with chronic obstructive pulmonary disease?
Statistics from Altmetric.com
Footnotes
Contributors This editorial was written by DMM, who is the guarantor for its contents.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests DM is a consultant to Astra-Zeneca, GlaxoSmithKline, Regeneron, Genentech, Up to Date, and the COPD Foundation, and a Medical Expert for the Schlesinger Law Firm.
Provenance and peer review Commissioned; internally peer reviewed.